Apr 3, 2018

Activating Natural Killer T cells to Combat Cancer

Posted by in category: biotech/medical

New research has identified the mechanisms responsible for enhancing immune system activity, offering new approaches for more effective cancer treatments and vaccines.

Invariant natural killer T (iNKT) cells are part of the immune system’s arsenal for fighting infection and defeating diseases like cancer. Finding ways to activate these potent cells more quickly could lead to more effective solutions to cancer and other diseases.

Read more

Comments are closed.